Supplementary Figure S4 from Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial

Autor:	Sandro Pignata, Yvonne G. Lin, Ching-Wei Chang, Victor K. Khor, Stephanie V. Blank, Premal H. Thaker, Carol Aghajanian, Aikou Okamoto, Andrew Green, Els Van Nieuwenhuysen, Thomas Reid, Mario Beiner, Tashanna Myers, Regina Berger, Charles Anderson, Kristina Lindemann, Michael Bookman, Cagatay Taskiran, Kathleen N. Moore, Austin Miller, Jalid Sehouli, Habib Hamidi, Luciana Molinero, Charles N. Landen
Rok vydání:	2023
Popis:	PFS by treatment arm according to TMB status (stratified by treatment approach, disease stage, and ECOG PS). A, TMB-low population. B, TMB-high population. CPB, paclitaxel, carboplatin, and bevacizumab.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab8226269a076ceaa25dfedd6f80336 https://doi.org/10.1158/1078-0432.22725021 Zobrazit plný text záznamu